| 1 |
33461346 | Erythropoietin promoter polymorphism is associated with treatment efficacy and severe hematologic toxicity for platinum-based chemotherapy. | 2021 Apr |
5 |
| 2 |
31798335 | The endogenous erythropoietin in correlation with other erythrocytic parameters in patients with head and neck squamous cell carcinoma treated with platinum-based induction chemotherapy. | 2019 |
1 |
| 3 |
21331363 | Epoetin Theta in Anaemic Cancer Patients Receiving Platinum-Based Chemotherapy: A Randomised Controlled Trial. | 2010 Sep |
2 |
| 4 |
17875340 | Early intervention with epoetin beta prevents severe anaemia in lung cancer patients receiving platinum-based chemotherapy: a subgroup analysis of the NeoPrevent study. | 2008 Feb |
3 |
| 5 |
18687658 | Erythropoietin inhibits apoptosis induced by photodynamic therapy in ovarian cancer cells. | 2008 Aug |
1 |
| 6 |
16874498 | Early intervention with epoetin beta prevents severe anaemia in patients with solid tumours receiving platinum-based chemotherapy: results of the NeoPrevent study. | 2007 Jan |
3 |
| 7 |
16169242 | Epoetin beta therapy in patients with solid tumours. | 2006 Apr |
1 |
| 8 |
16476840 | Early Intervention with epoetin alfa during platinum-based chemotherapy: an analysis of quality-of-life results of a multicenter, randomized, controlled trial compared with population normative data. | 2006 Feb |
2 |
| 9 |
16476841 | Early intervention with epoetin alfa during platinum-based chemotherapy: an analysis of the results of a multicenter, randomized, controlled trial based on initial hemoglobin level. | 2006 Feb |
2 |
| 10 |
16570051 | Epoetin alfa in platinum-treated ovarian cancer patients: results of a multinational, multicentre, randomised trial. | 2006 Apr 10 |
1 |
| 11 |
16725267 | European guidelines for the management of chemotherapy-induced anaemia and health economic aspects of treatment. | 2006 |
1 |
| 12 |
16739308 | Epoetin beta (NeoRecormon) therapy in patients with solid tumours receiving platinum and non-platinum chemotherapy: a meta-analysis. | 2006 Jan-Feb |
2 |
| 13 |
15953714 | Effects of early intervention with epoetin alfa on transfusion requirement, hemoglobin level and survival during platinum-based chemotherapy: Results of a multicenter randomised controlled trial. | 2005 Jul |
1 |
| 14 |
15474662 | Role of epoetin in the management of anaemia in patients with lung cancer. | 2004 Nov |
1 |
| 15 |
12565986 | Assessing the clinical significance of health-related quality of life (HrQOL) improvements in anaemic cancer patients receiving epoetin alfa. | 2003 Feb |
1 |
| 16 |
12566906 | Prevention of anemia in patients with solid tumors receiving platinum-based chemotherapy by recombinant human Erythropoietin (rHuEpo): a prospective, open label, randomized trial by the Hellenic Cooperative Oncology Group. | 2003 |
2 |
| 17 |
12883695 | Comparing the efficacy and safety of fixed versus weight-based dosing of epoetin alpha in anemic cancer patients receiving platinum-based chemotherapy. | 2003 Sep-Oct |
1 |
| 18 |
14735555 | Epoetin alfa corrects anemia and improves quality of life in patients with hematologic malignancies receiving non-platinum chemotherapy. | 2003 Dec |
1 |
| 19 |
17472238 | Recombinant human erythropoietin for platinum-based chemotherapy-induced anaemia: A single-centre randomised study. | 2003 Apr-Jun |
1 |
| 20 |
11881794 | Reduction in transfusion requirements with early epoetin alfa treatment in pediatric patients with solid tumors: a case-control study. | 2002 Mar |
1 |
| 21 |
12217742 | Prediction of the need for red cell transfusion in newly diagnosed ovarian cancer patients undergoing platinum-based treatment. | 2002 Sep |
1 |
| 22 |
12436449 | Response predicting factors to recombinant human erythropoietin in cancer patients undergoing platinum-based chemotherapy. | 2002 Dec 1 |
2 |
| 23 |
11346705 | Peripheral blood progenitor cell collection after epirubicin, paclitaxel, and cisplatin combination chemotherapy using EPO-based cytokine regimens: a randomized comparison of G-CSF and sequential GM-/G-CSF. | 2001 May |
1 |
| 24 |
10930966 | Plasma erythropoietin concentrations in patients receiving intensive platinum or nonplatinum chemotherapy. | 2000 Aug |
1 |
| 25 |
11090055 | Cadmium and platinum suppression of erythropoietin production in cell culture: clinical implications. | 2000 Dec 1 |
1 |
| 26 |
10408844 | Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer. | 1999 May |
1 |
| 27 |
10477381 | [Updating 1999 of Standards, Options and Recommendations (SOR) for the clinical use of erythropoietin in oncology. FEDERATION OF THE FRENCH CANCER CENTRES (FNCLCC)]. | 1999 Jul-Aug |
1 |
| 28 |
10582148 | Chemotherapy of non-small-cell lung cancer: role of erythropoietin in the management of anemia. | 1999 |
2 |
| 29 |
9671326 | Management of chemotherapy-induced anemia in solid tumors. | 1998 Jun |
1 |
| 30 |
9752298 | [Standards, Options, and Recommendations for using erythropoietin in cancerology]. | 1998 Apr |
1 |
| 31 |
9785333 | Recombinant human erythropoietin in the treatment of cancer-related or chemotherapy-induced anaemia in patients with solid tumours. | 1998 Aug |
2 |
| 32 |
9813972 | The effect of subcutaneous recombinant human erythropoietin (r-HuEPO) on anemia in cancer patients receiving platinum-based chemotherapy. | 1998 May |
1 |
| 33 |
9487380 | [Diagnostic approach to the anemic cancer patient]. | 1997 Jul-Aug |
1 |
| 34 |
9487381 | [Use of erythropoietin in oncology]. | 1997 Jul-Aug |
4 |
| 35 |
9765749 | Erythropoietin in the management of patients with nonhematologic cancer receiving chemotherapy. Systemic Treatment Program Committee. | 1997 Aug |
2 |